Winograd, Evan
Germano, Isabelle
Wen, Patrick
Olson, Jeffrey J.
Ormond, D. Ryan http://orcid.org/0000-0001-7027-2915
Article History
Received: 8 September 2021
Accepted: 11 October 2021
First Online: 25 October 2021
Declarations
:
: All Guideline Task Force members were required to disclose all potential COIs prior to beginning work on the guideline, using the COI disclosure form of the AANS/CNS Joint Guidelines Review Committee. The CNS Guidelines Committee and Guideline Task Force Chair reviewed the disclosures and either approved or disapproved the nomination and participation on the task force. The CNS Guidelines Committee and Guideline Task Force Chair may approve nominations of task force members with possible conflicts and restrict the writing, reviewing, and/or voting privileges of that person to topics that are unrelated to the possible COIs. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this series of articles.
: This article does not contain any studies with human participants performed by any of the authors.
: The author has ensured all data and materials as well as software applications or custom code supports their published claims and comply with field standards.
: These guidelines were funded exclusively by the Congress of Neurological Surgery and the Joint Section on Tumors of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, which received no funding from any outside commercial sources to support the development of this document.
Free to read: This content has been made available to all.